Abstract
Age-related macular degeneration (AMD) is the leading cause of irreversible blindness in elderly populations worldwide. Inflammation, among many factors, has been suggested to play an important role in AMD pathogenesis. Interleukin 17 (IL-17) is a proinflammatory cytokine that has been implicated in the pathogenesis of various autoimmune diseases. In the current study, we examined two single nucleotide polymorphisms (SNPs), rs2275913G/A and rs3748067C/T, in the IL-17A gene between AMD patients and healthy controls. Results showed that rs2275913AA genotype and rs3748067TT genotype were associated with increased susceptibility to AMD (hazard ratio [HR], 1.75; 95 % confidence interval [CI], 1.07 to 3.02; P = 0.023, and HR, 2.12; 95 % CI, 1.26 to 4.01; P = 0.004; data were adjusted for age and sex). Next, we investigated the functional relevance of the two SNPs. In vitro stimulated peripheral blood mononuclear cells (PBMCs) from subjects possessing the rs2275913AA genotype produced significantly more IL-17 than those with the GG genotype. However, PBMCs with rs3748067TT genotype revealed significantly higher IL-17 production than those with rs3748067CC genotype only in AMD patients but not in controls. These data indicate IL-17A polymorphisms are associated with increased risk of AMD probably by affecting gene expression.
Similar content being viewed by others
References
Ardeljan, D., Y. Wang, S. Park, D. Shen, X.K. Chu, C.R. Yu, M. Abu-Asab, J. Tuo, C.G. Eberhart, T.W. Olsen, R.F. Mullins, G. White, S. Wadsworth, A. Scaria, and C.C. Chan. 2014. Interleukin-17 retinotoxicity is prevented by gene transfer of a soluble interleukin-17 receptor acting as a cytokine blocker: implications for age-related macular degeneration. PLoS One 9: e95900.
Bar, E., P.G. Whitney, K. Moor, C. Reis, E. Sousa, and S. LeibundGut-Landmann. 2014. IL-17 regulates systemic fungal immunity by controlling the functional competence of NK cells. Immunity 40: 117–127.
Benedetti, G., and P. Miossec. 2014. Interleukin 17 contributes to the chronicity of inflammatory diseases such as rheumatoid arthritis. European Journal of Immunology 44: 339–347.
Blasiak, J., G. Petrovski, Z. Vereb, A. Facsko, and K. Kaarniranta. 2014. Oxidative stress, hypoxia, and autophagy in the neovascular processes of age-related macular degeneration. BioMed Research International 2014: 768026.
Espinoza, J.L., A. Takami, K. Nakata, M. Onizuka, T. Kawase, H. Akiyama, K. Miyamura, Y. Morishima, T. Fukuda, Y. Kodera, and S. Nakao. 2011. A genetic variant in the IL-17 promoter is functionally associated with acute graft-versus-host disease after unrelated bone marrow transplantation. PLoS One 6: e26229.
Frleta, M., S. Siebert, and I.B. McInnes. 2014. The interleukin-17 pathway in psoriasis and psoriatic arthritis: disease pathogenesis and possibilities of treatment. Current Rheumatology Reports 16: 414.
Gu, C., L. Wu, and X. Li. 2013. IL-17 family: cytokines, receptors and signaling. Cytokine 64: 477–485.
Hayashi, R., T. Tahara, H. Shiroeda, T. Saito, M. Nakamura, M. Tsutsumi, T. Shibata, and T. Arisawa. 2013. Influence of IL17A polymorphisms (rs2275913 and rs3748067) on the susceptibility to ulcerative colitis. Clinical and Experimental Medicine 13: 239–244.
Kerami, Z., N.W. Duijvis, E.W. Vogels, F.H. van Dooren, P.D. Moerland, and A.A. Te Velde. 2014. Effect of interleukin-17 on gene expression profile of fibroblasts from Crohn’s disease patients. Journal of Crohn’s & Colitis. doi:10.1016/j.crohns.2014.02.009.
Kwa, F.A, and T.R. Thrimawithana. 2014. Epigenetic modifications as potential therapeutic targets in age-related macular degeneration and diabetic retinopathy. Drug Discovery Today. doi:10.1016/j.drudis.2014.03.026.
Lam, M., L. Hull, R. McLachlan, K. Snidvongs, D. Chin, E. Pratt, L. Kalish, R. Sacks, P. Earls, W. Sewell, and R.J. Harvey. 2013. Clinical severity and epithelial endotypes in chronic rhinosinusitis. International Forum of Allergy & Rhinology 3: 121–128.
Li, N., Q. Zhu, Z. Li, Q. Han, G. Zhang, J. Chen, Y. Lv, F. Xing, Y. Chen, X. Zeng, and Z. Liu. 2014. IL17A gene polymorphisms, serum IL-17A and IgE levels, and hepatocellular carcinoma risk in patients with chronic hepatitis B virus infection. Molecular Carcinogenesis 53: 447–457.
Liu, B., L. Wei, C. Meyerle, J. Tuo, H.N. Sen, Z. Li, S. Chakrabarty, E. Agron, C.C. Chan, M.L. Klein, E. Chew, F. Ferris, and R.B. Nussenblatt. 2011. Complement component C5a promotes expression of IL-22 and IL-17 from human T cells and its implication in age-related macular degeneration. Journal of Translational Medicine 9: 1–12.
Maalmi, H., A. Beraies, R. Charad, J. Ammar, K. Hamzaoui, and A. Hamzaoui. 2014. IL-17A and IL-17F genes variants and susceptibility to childhood asthma in Tunisia. The Journal of Asthma: Official Journal of the Association for the Care of Asthma 51: 348–354.
Moon, S.J., J.S. Park, Y.J. Woo, M.A. Lim, S.M. Kim, S.Y. Lee, E.K. Kim, H.J. Lee, W.S. Lee, S.H. Park, J.H. Jeong, S.H. Park, H.Y. Kim, M.L. Cho, and J.K. Min. 2014. Rebamipide suppresses collagen-induced arthritis through reciprocal regulation of th17/treg cell differentiation and heme oxygenase 1 induction. Arthritis and Rheumatology (Hoboken, N.J.) 66: 874–885.
Ng, T.K., V.R. Fortino, D. Pelaez, and H.S. Cheung. 2014. Progress of mesenchymal stem cell therapy for neural and retinal diseases. World Journal of Stem Cells 6: 111–119.
Ocejo-Vinyals, J.G., E.P. de Mateo, M.A. Hoz, J.L. Arroyo, R. Aguero, F. Ausin, and M.C. Farinas. 2013. The IL-17G-152A single nucleotide polymorphism is associated with pulmonary tuberculosis in northern Spain. Cytokine 64: 58–61.
Omrane, I., R. Marrakchi, O. Baroudi, A. Mezlini, H. Ayari, I. Medimegh, N. Stambouli, N. Kourda, H. Bouzaienne, N. Uhrhammer, K. Bougatef, Y.J. Bignon, and A. Benammar-Elgaaied. 2014. Significant association between interleukin-17A polymorphism and colorectal cancer. Tumour Biology: the Journal of the International Society for Oncodevelopmental Biology and Medicine. doi:10.1007/s13277-014-1890-4.
Qinghai, Z., W. Yanying, C. Yunfang, Z. Xukui, and Z. Xiaoqiao. 2014. Effect of interleukin-17A and interleukin-17F gene polymorphisms on the risk of gastric cancer in a Chinese population. Gene 537: 328–332.
Sato, D.K., I. Nakashima, A. Bar-Or, T. Misu, C. Suzuki, S. Nishiyama, H. Kuroda, K. Fujihara, and M. Aoki. 2014. Changes in Th17 and regulatory T cells after fingolimod initiation to treat multiple sclerosis. Journal of Neuroimmunology 268: 95–98.
Taylor, P.R., S. Roy, S.M. Leal Jr., Y. Sun, S.J. Howell, B.A. Cobb, X. Li, and E. Pearlman. 2014. Activation of neutrophils by autocrine IL-17A-IL-17RC interactions during fungal infection is regulated by IL-6, IL-23, RORgammat and dectin-2. Nature Immunology 15: 143–151.
Wei, L., B. Liu, J. Tuo, D. Shen, P. Chen, Z. Li, X. Liu, J. Ni, P. Dagur, H.N. Sen, S. Jawad, D. Ling, S. Park, S. Chakrabarty, C. Meyerle, E. Agron, F.L. Ferris 3rd, E.Y. Chew, J.P. McCoy, E. Blum, P.J. Francis, M.L. Klein, R.H. Guymer, P.N. Baird, C.C. Chan, and R.B. Nussenblatt. 2012. Hypomethylation of the IL17RC promoter associates with age-related macular degeneration. Cell Reports 2: 1151–1158.
Yu, H., X. Zou, L. Peng, Y. Wang, C. Zhang, B. Chen, and Y. Zou. 2013. Effect of soluble inducible costimulator level and its polymorphisms on age-related macular degeneration. DNA and Cell Biology 32: 717–721.
Yu, X.H., N. Jiang, X.L. Zheng, F.S. Cayabyab, Z.B. Tang, and C.K. Tang. 2014. Interleukin-17A in lipid metabolism and atherosclerosis. Clinica Chimica Acta; International Journal of Clinical Chemistry 431C: 33–39.
Conflict of Interest
No conflict of interest exists.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Zhang, S., Liu, Y., Lu, S. et al. Genetic Variants of Interleukin 17A Are Functionally Associated with Increased Risk of Age-Related Macular Degeneration. Inflammation 38, 658–663 (2015). https://doi.org/10.1007/s10753-014-9973-3
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10753-014-9973-3